• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2021 年俄罗斯西北部地区 COVID-19 的流行病学特征。

Epidemiological Features of COVID-19 in Northwest Russia in 2021.

机构信息

Saint Petersburg Pasteur Institute, 14 Ulitsa Mira, 197101 Saint Petersburg, Russia.

Martsinovsky Institute of Medical Parasitology, Tropical and Vector Borne Diseases, Sechenov First Moscow State Medical University, 119435 Moscow, Russia.

出版信息

Viruses. 2022 Apr 29;14(5):931. doi: 10.3390/v14050931.

DOI:10.3390/v14050931
PMID:35632673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9147892/
Abstract

Appearing in Wuhan (China) and quickly spreading across the globe, the novel coronavirus infection quickly became a significant threat to global health. The year 2021 was characterized by both increases and decreases in COVID-19 incidence, and Russia was no exception. In this work, we describe regional features in the Northwestern federal district (FD) of Russia of the pandemic in 2021 based on Rospotrebnadzor statistics and data from SARS-CoV-2 genetic monitoring provided by the Saint Petersburg Pasteur Institute as a part of epidemiological surveillance. The epidemiological situation in the studied region was complicated by the presence of the megacity Saint Petersburg, featuring a high population density and its status as an international transport hub. COVID-19 incidence in the Northwestern FD fluctuated throughout the year, with two characteristic maxima in January and November. An analysis of fluctuations in the age structure, severity of morbidity, mortality rates, and the level of population vaccination in the region during the year is given. Assessment of epidemiological indicators was carried out in relation to changes in locally circulating genetic variants. It was seen that, during 2021, so-called variants of concern (VOC) circulated in the region (Alpha, Beta, Delta, Omicron), with Delta variant strains dominating from June to December. They successively replaced the variants of lines 20A and 20B circulating at the beginning of the year. An epidemiological feature of the northwestern region is the AT.1 variant, which was identified for the first time and later spread throughout the region and beyond its borders. Its share of the regional viral population reached 28.2% in May, and sporadic cases were observed until September. It has been shown that genetic variants of AT.1 lineages distributed in Russia and Northern Europe represent a single phylogenetic group at the base of the 20B branch on the global phylogenetic tree of SARS-CoV-2 strains. The progression of the COVID-19 pandemic occurred against the background of a vaccination campaign. The findings highlight the impact of vaccination on lowering severe COVID-19 case numbers and the mortality rate, despite ongoing changes in circulating SARS-CoV-2 genetic variants.

摘要

新型冠状病毒感染症(COVID-19)从武汉(中国)出现并迅速蔓延至全球,迅速成为全球健康的重大威胁。2021 年,COVID-19 的发病率既有增加也有减少,俄罗斯也不例外。在这项工作中,我们根据 Rospotrebnadzor 的统计数据和圣彼得堡巴斯德研究所提供的 SARS-CoV-2 遗传监测数据,描述了俄罗斯西北部联邦区(FD)在 2021 年大流行的区域特征,该研究所作为流行病学监测的一部分。由于存在人口密度高且作为国际交通枢纽的大城市圣彼得堡,研究区域的流行病学情况变得复杂。COVID-19 在该地区的发病率全年波动,1 月和 11 月有两个明显的高峰。本文对该地区全年的年龄结构、发病严重程度、死亡率和人口接种水平的波动进行了分析。对流行病学指标的评估是根据当地流行的遗传变异进行的。结果表明,2021 年在该地区流行的所谓关注变异株(VOC)(Alpha、Beta、Delta、Omicron),Delta 变异株从 6 月到 12 月占主导地位。它们相继取代了年初流行的 20A 和 20B 变异株。该地区的一个流行病学特征是 AT.1 变异株,该变异株首次被发现,后来在该地区及其边界以外传播。其在该地区病毒种群中的比例在 5 月达到 28.2%,直到 9 月仍有散发病例。结果表明,分布在俄罗斯和北欧的 AT.1 谱系的遗传变异株代表 SARS-CoV-2 株全球系统发育树上 20B 分支基部的单一系统发育群。COVID-19 大流行的进展是在接种疫苗运动的背景下发生的。研究结果强调了接种疫苗对降低严重 COVID-19 病例数量和死亡率的影响,尽管循环中的 SARS-CoV-2 遗传变异仍在不断变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/a0fe7b60d8bb/viruses-14-00931-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/5279f8c4a5a5/viruses-14-00931-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/db9b8e9e278e/viruses-14-00931-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/6acdca58ae35/viruses-14-00931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/ca32862dad8c/viruses-14-00931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/cbef157812b5/viruses-14-00931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/5b7a1532ee30/viruses-14-00931-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/10a0441d371e/viruses-14-00931-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/393922c5d1ec/viruses-14-00931-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/4e72c5468703/viruses-14-00931-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/a0fe7b60d8bb/viruses-14-00931-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/5279f8c4a5a5/viruses-14-00931-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/db9b8e9e278e/viruses-14-00931-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/6acdca58ae35/viruses-14-00931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/ca32862dad8c/viruses-14-00931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/cbef157812b5/viruses-14-00931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/5b7a1532ee30/viruses-14-00931-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/10a0441d371e/viruses-14-00931-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/393922c5d1ec/viruses-14-00931-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/4e72c5468703/viruses-14-00931-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/9147892/a0fe7b60d8bb/viruses-14-00931-g008.jpg

相似文献

1
Epidemiological Features of COVID-19 in Northwest Russia in 2021.2021 年俄罗斯西北部地区 COVID-19 的流行病学特征。
Viruses. 2022 Apr 29;14(5):931. doi: 10.3390/v14050931.
2
COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.俄罗斯圣彼得堡的 COVID-19 疫情:结合基于人群的血清学研究和监测数据。
PLoS One. 2022 Jun 15;17(6):e0266945. doi: 10.1371/journal.pone.0266945. eCollection 2022.
3
Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.SARS-CoV-2 的分子进化:2019 年 12 月至 2022 年 8 月。
J Med Virol. 2023 Jan;95(1):e28366. doi: 10.1002/jmv.28366.
4
An Early SARS-CoV-2 Omicron Outbreak in a Dormitory in Saint Petersburg, Russia.俄罗斯圣彼得堡一宿舍内的早期 SARS-CoV-2 奥密克戎疫情。
Viruses. 2023 Jun 22;15(7):1415. doi: 10.3390/v15071415.
5
Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations.一种新型 SARS-CoV-2 遗传变异体的特征,其 Spike 蛋白发生了独特的突变。
Viruses. 2021 May 29;13(6):1029. doi: 10.3390/v13061029.
6
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.关注的紧急 SARS-CoV-2 变异株:用于快速检测和监测的新型多重实时 RT-PCR 检测方法。
Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21.
7
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
8
The Development of the SARS-CoV-2 Epidemic in Different Regions of Siberia in the 2020-2022 Period.2020-2022 年期间,西伯利亚不同地区的 SARS-CoV-2 疫情发展情况。
Viruses. 2023 Sep 27;15(10):2014. doi: 10.3390/v15102014.
9
Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: a test-negative case-control study.俄罗斯圣彼得堡 Gam-COVID-Vac、EpiVacCorona 和 CoviVac 在德尔塔和奥密克戎变异株流行期间对肺部损伤的有效性:一项病例对照研究。
Respir Res. 2022 Oct 10;23(1):276. doi: 10.1186/s12931-022-02206-3.
10
HLA Genotypes in Patients with Infection Caused by Different Strains of SARS-CoV-2.感染不同 SARS-CoV-2 株的患者的 HLA 基因型。
Int J Environ Res Public Health. 2022 Oct 28;19(21):14024. doi: 10.3390/ijerph192114024.

引用本文的文献

1
COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.COVID-19 发病率与区域检测策略、疫苗接种覆盖率和疫苗类型的关系。
Viruses. 2023 Oct 30;15(11):2181. doi: 10.3390/v15112181.
2
The Development of the SARS-CoV-2 Epidemic in Different Regions of Siberia in the 2020-2022 Period.2020-2022 年期间,西伯利亚不同地区的 SARS-CoV-2 疫情发展情况。
Viruses. 2023 Sep 27;15(10):2014. doi: 10.3390/v15102014.
3
The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review.

本文引用的文献

1
Origins of SARS-CoV-2: window is closing for key scientific studies.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的起源:关键科学研究的时间窗口正在关闭。
Nature. 2021 Aug;596(7873):482-485. doi: 10.1038/d41586-021-02263-6.
2
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies.COVID-19(CoviVac)灭活疫苗在临床前研究中的长期体液免疫原性、安全性和保护效力。
Emerg Microbes Infect. 2021 Dec;10(1):1790-1806. doi: 10.1080/22221751.2021.1971569.
3
Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021.
不同国家 SARS-CoV-2 感染人群中奥密克戎变异株的相对流行率:系统评价。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2212568. doi: 10.1080/21645515.2023.2212568.
4
Correction: Gladkikh et al. Epidemiological Features of COVID-19 in Northwest Russia in 2021. 2022, , 931.更正:Gladkikh等人。2021年俄罗斯西北部COVID-19的流行病学特征。2022年,,931。
Viruses. 2023 May 18;15(5):1190. doi: 10.3390/v15051190.
5
HLA Genotypes in Patients with Infection Caused by Different Strains of SARS-CoV-2.感染不同 SARS-CoV-2 株的患者的 HLA 基因型。
Int J Environ Res Public Health. 2022 Oct 28;19(21):14024. doi: 10.3390/ijerph192114024.
6
Uninvited Guest: Arrival and Dissemination of Omicron Lineage SARS-CoV-2 in St. Petersburg, Russia.不速之客:奥密克戎谱系新冠病毒在俄罗斯圣彼得堡的出现与传播
Microorganisms. 2022 Aug 20;10(8):1676. doi: 10.3390/microorganisms10081676.
截至2021年6月,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株的传播性增加及其在全球的传播情况。
Euro Surveill. 2021 Jun;26(24). doi: 10.2807/1560-7917.ES.2021.26.24.2100509.
4
SARS-CoV-2 variants, spike mutations and immune escape.SARS-CoV-2 变体、刺突突变和免疫逃逸。
Nat Rev Microbiol. 2021 Jul;19(7):409-424. doi: 10.1038/s41579-021-00573-0. Epub 2021 Jun 1.
5
Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations.一种新型 SARS-CoV-2 遗传变异体的特征,其 Spike 蛋白发生了独特的突变。
Viruses. 2021 May 29;13(6):1029. doi: 10.3390/v13061029.
6
Twelve years of SAMtools and BCFtools.SAMtools 和 BCFtools 十二年。
Gigascience. 2021 Feb 16;10(2). doi: 10.1093/gigascience/giab008.
7
Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia.俄罗斯 SARS-CoV-2 疫情早期的基因组流行病学研究。
Nat Commun. 2021 Jan 28;12(1):649. doi: 10.1038/s41467-020-20880-z.
8
New variant of SARS-CoV-2 in UK causes surge of COVID-19.英国出现的新冠病毒新变种导致新冠肺炎病例激增。
Lancet Respir Med. 2021 Feb;9(2):e20-e21. doi: 10.1016/S2213-2600(21)00005-9. Epub 2021 Jan 5.
9
One-step quantitative RT-PCR assay with armored RNA controls for detection of SARS-CoV-2.一步法实时 RT-PCR 检测试剂盒,含装甲 RNA 对照,用于 SARS-CoV-2 的检测。
J Med Virol. 2021 Mar;93(3):1694-1701. doi: 10.1002/jmv.26540. Epub 2020 Oct 5.
10
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.两种配方的基于 rAd26 和 rAd5 载体的异源初免-加强型 COVID-19 疫苗的安全性和免疫原性:来自俄罗斯的两项开放、非随机的 1/2 期研究。
Lancet. 2020 Sep 26;396(10255):887-897. doi: 10.1016/S0140-6736(20)31866-3. Epub 2020 Sep 4.